(BUSINESS WIRE)--Regulus Therapeutics Inc., a leading microRNA therapeutics company, announced today that it has promoted Garry E. Menzel, Ph.D., to Chief Operating Officer and Executive Vice President of Finance. In this new expanded role Dr. Menzel will oversee the Company’s operations and finances, setting strategy to support the advancement of multiple microRNA therapeutic programs towards the clinic.
